Omega Funds's book
23 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Resilience (Blue Ash) | — | $9.4B | — | — | |
| Synthekine | — | $500.0M | — | — | |
| Aviceda Therapeutics | — | $346.5M | — | — | |
| Third Arc Bio | — | $314.0M | — | — | |
| Antares Therapeutics | — | $299.0M | — | — | |
| Alveus Therapeutics | — | $275.2M | — | — | |
| Marea | — | $272.0M | — | — | |
| Vanqua Bio | — | $270.0M | — | — | |
| Artios | Drug Discovery | $260.3M | — | — | |
| Alleviant Medical | — | $260.0M | — | — | |
| + 13 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 23 recorded positions
- ·Watchlist + alerts for Omega Funds's activity
Create free account
No card required